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Increasing antibiotic resistance in pathogenic microorganisms has led to renewed
interest in bacteriophage therapy in both humans and animals. A “Trojan Horse”
approach utilizing liposome encapsulated phages may facilitate access to phagocytic
cells infected with intracellular pathogens residing therein, e.g., to treat infections
caused by Mycobacterium tuberculosis, Listeria, Salmonella, and Staphylococcus
sp. Additionally, liposome encapsulated phages may adhere to and diffuse within
mucosa harboring resistant bacteria which are challenges in treating respiratory and
gastrointestinal infections. Orally delivered phages tend to have short residence times
in the gastrointestinal tract due to clinical symptoms such as diarrhea; this may be
addressed through mucoadhesion of liposomes. In the present study we have evaluated
the use of a microfluidic based technique for the encapsulation of bacteriophages in
liposomes having mean sizes between 100 and 300 nm. Encapsulation of two model
phages was undertaken, an Escherichia coli T3 podovirus (size ∼65 nm) and a myovirus
Staphylococcus aureus phage K (capsid head ∼80 nm and phage tail length ∼200 nm).
The yield of encapsulated T3 phages was 109 PFU/ml and for phage K was much
lower at 105 PFU/ml. The encapsulation yield for E. coli T3 phages was affected by
aggregation of T3 phages. S. aureus phage K was found to interact with the liposome
lipid bilayer resulting in large numbers of phages bound to the outside of the formed
liposomes instead of being trapped inside them. We were able to inactivate the liposome
bound S. aureus K phages whilst retaining the activity of the encapsulated phages in
order to estimate the yield of microfluidic encapsulation of large tailed phages. Previous
published studies on phage encapsulation in liposomes may have overestimated the
yield of encapsulated tailed phages. This overestimation may affect the efficacy of phage
dose delivered at the site of infection. Externally bound phages would be inactivated in
the stomach acid resulting in low doses of phages delivered at the site of infection further
downstream in the gastrointestinal tract.
Keywords: bacteriophage therapy, E. coli, intracellular infections, liposome fabrication, microfluidics,
nanoencapsulation, S. aureus
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INTRODUCTION
The widespread inappropriate use of antibiotics in both humans
(clinical medicine) and animals (livestock industry) worldwide
has led to an acceleration in the emergence and global spread
of multidrug antibiotic resistant bacterial clones (Morgan et al.,
2011). The problem of antibiotic resistance is a complex one
requiring global coordination for antibiotic stewardship to
preserve the efficacy of current treatments. In much of the world
outside Europe and North America, lifesaving antibiotics are
sold without a prescription or oversight by health professionals
(Laxminarayan et al., 2013). In the period between 1940 and
1962, 20 new classes of antibiotics were introduced to the market;
however, since 1962, there has been a discovery void with only
two new classes reaching this stage (Coates et al., 2011). The
speed of development of resistance has been faster than the rate of
discovery (Kelly et al., 2016). The substantial public health threat
from antibiotic resistance includes jeopardizing effectiveness of
treatments in modern medicine from minor elective surgeries to
cancer therapy.
The ESKAPE pathogens (Enterococcus faecium,
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter
baumannii, Pseudomonas aeruginosa, and Enterobacter species)
represent a key group of commonly occurring Multi-Drug
Resistant organisms at the heart of the antibiotic resistance
crisis (Schooley et al., 2017). Initiatives to develop new
therapeutic approaches with novel mechanisms of activity
against MDR bacterial pathogens include the potential use of
lytic bacteriophages (Summers, 2001; Czaplewski et al., 2016).
Lytic bacteriophages (phages) are viruses that infect and kill
bacteria, and they represent a promising approach to targeting
bacterial infections in a treatment known as phage therapy
(Alisky et al., 1998; Abedon, 2009; Abedon et al., 2011; Allen
et al., 2014). The specificity of bacteriophages and their potential
role in maintaining healthy microbiota makes them an attractive
alternative to employing antibiotics. Technical advances are
reducing the cost, processing and sequencing times of next-
generation sequencing (NGS), thereby allowing rapid culture
independent identification of disease causing bacteria (Toma
et al., 2014). These developments increase the opportunities for
using narrow spectrum antibiotics where the infection causing
bacterial agent is known, thereby opening-up the possibility of
employing phages for therapeutic purposes (Malik et al., 2017).
A number of recent studies in animals and humans have been
carried out to investigate the clinical safety and therapeutic or
prophylactic efficacy of phages against P. aeruginosa, S. aureus,
A. baumannii, Escherichia coli, and Salmonella enteritidis
(Wright et al., 2009; Lim et al., 2012; Sarker et al., 2016; Schooley
et al., 2017).
Limitations regarding the broad utility of phage therapy
for the treatment of bacterial infections include narrow host
ranges of individual phages and bacterial host resistance
leading to phage resistant mutant. There is some debate as
to whether bacteriophages would be able to diffuse across
eukaryotic cell membranes killing intracellular bacteria infecting
macrophages and other eukaryotic cells. Some recent in vitro
studies have shown free phage entry into macrophages and
other non-phagocytic eukaryotic cells however, the mechanisms
of entry remain unclear (Nieth et al., 2015b; Zhang et al.,
2017). Intracellular phage entry into eukaryotic cells has been
explained to occur either through phagocytosis of phage
infected bacteria or via bacterial induced endocytosis (Finlay,
1997). Important multi-drug resistant intracellular pathogens
include those causing chlamydia, salmonella, staphylococcal, and
mycobacterial infections, as well as infections due to Brucella
abortus, Burkholderia cenocepacia, K. pneumoniae, Legionella
pneumophilia, and Listeria monocytogenes (Nieth et al., 2015a;
Singla et al., 2016b). Use of phage cocktails permits broadening
of the host range whilst judicious selection of phages making-
up the cocktail targeting different receptors tends to reduce
the risk of resistance arising in host bacteria due to random
mutations (Tanji et al., 2005; Denou et al., 2009; Yen et al., 2017).
In chronic infections phage treatment may be compromised
by the adaptive host immune response (anti-phage antibodies)
leading to clearance of delivered phages lowering the phage
titer at the site of infection resulting in poor efficacy of
phage therapy (Dabrowska et al., 2005). Another considerable
challenge is associated with accessibility of phages to a wide
range of pathogenic bacteria residing within mucosa and
biofilms including highly resistant strains of Bordetella pertussis
(whooping cough), E. coli (diarrheas, meningitis, urinary
tract infections), Helicobacter pylori (ulcers, gastritis), Neisseria
gonorrhoea (gonorrhoea), Neisseria meningitidis (meningitis), P.
aeruginosa (infections in people suffering from cystic fibrosis),
S. aureus (wound associated infections e.g., diabetic foot
ulcers), streptococci (meningitis, otitis media, pharyngitis, scarlet
fever), etc.
Encapsulation of phages in liposomes may address some
of the challenges associated with the development of effective
phage therapy discussed above. Liposomes are composed of
phospholipids, which self-assemble and self-enclose to form
spheres of lipid bilayers with an inner aqueous core which
may be designed to contain therapeutic agents such as phages.
Liposomes may aid in shielding phages from the action of
the reticuloendothelial system thereby increasing the length
of time of circulation of phages instead of having to find
long-circulating mutant phage strains (Merril et al., 1996). A
previous study demonstrated that non-virulent Mycobacterium
smegmatis and Mycobacterium avium transiently infected with
the lytic phage TM4 were able to deliver the phage into
Mycobacterium tuberculosis infected macrophages in a “Trojan
Horse” approach (Broxmeyer et al., 2002). In a similar manner,
liposome encapsulated phages may permit phage access to
intracellular pathogens for the treatment of serious infections,
such as those caused by M. tuberculosis, S. aureus, and E. coli
(Nieth et al., 2015b).
Liposomes have been used to encapsulate a vast variety of
cargos, like hydrophilic and hydrophobic drugs, proteins, living
cells, nanoparticles, quantum dots, plasmid DNAs (Pattni et al.,
2015). Ideally, liposome encapsulation techniques should allow
full control over liposome formulation composition (e.g., for
regulatory safety compliance) as well as control over vesicle
size and size distribution which are important factors as they
affect the encapsulated dose as well as in vivo circulation times
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and pharmacokinetics of the encapsulated active ingredient
and its biodistribution (Sawant and Torchilin, 2012b). The
liposome production process needs to be scalable and have
a low environmental impact (Torchilin, 2005). Since their
discovery in the 60s, several methods for the preparation
of liposomes have been developed (Sawant and Torchilin,
2012a). However, classical techniques (e.g., thin film hydration,
sonication, solvent dispersion, detergent removal, dilution) as
well as sophisticated/innovative ones (e.g., use of supercritical
fluids) do not completely fulfill the requirements for an ideal
encapsulation process and lack adequate control over liposome
production. The choice of the manufacturing technique is
constrained by specific requirements and is quite often a
compromise. Recently, microfluidic approaches have been used
to address some of the constraints of other liposome production
methods (van Swaay and deMello, 2013). Microfluidic devices
offer many advantages over traditional liposome fabrication
methods, such as control over the average size of liposomes,
narrow particle size distribution, portability, integration and
automation possibilities, and small reagent consumption thereby
allowing rapid screening of formulations and production
parameters. Liposome size and size distribution affect crucial
characteristics including cargo release profile, loading capacity,
biodegradation rate, biodistribution, and liposome stability over
time.
There are relatively few published studies on phage
encapsulation in liposomes (Nieth et al., 2015a; Singla et al.,
2015, 2016a,b; Chibber et al., 2017; Leung et al., 2018).
Recent animal studies in chickens have shown that liposome
encapsulated Salmonella phages were significantly more stable
upon exposure to stomach acid and showed longer intestinal
retention times in comparison with free phages and this
resulted in better treatment outcomes (Colom et al., 2015).
Liposome encapsulated K. pneumoniae phage delivered via
intraperitoneal injection remained in the systemic circulation
of mice longer than the corresponding free phages (Singla
et al., 2015). Liposomal nanoparticles (NPs) may be able to
penetrate deep into the intestinal mucosa to reach infection
sites, thereby improving the efficacy of phage therapy by
targeting pathogenic bacteria residing in these difficult to
access niches (Takeuchi et al., 2005). The residence time
of NPs has been found to be longer compared to larger
particles. For instance, chitosan coated sub-micron liposomes
showed longer residence times in the GI tract than larger
multilamellar vesicles attributed to their high penetration
ability into the mucosa (Takeuchi et al., 2005; Thirawong et al.,
2008).
The aim of this study was to investigate the use of a novel co-
flow microfluidic glass capillary device for the encapsulation of
bacteriophages in sub-micron sized liposomes. Previous studies
have typically employed a thin-film hydration method for
liposome preparation which does not afford precise control over
the resulting liposome size and phage encapsulation. The effects
of lipid composition, phage titer and experimental procedures
related to encapsulation of two model phages, an E. coli T3
podovirus and a myovirus Staphylococcus phage K, have been
investigated.
MATERIALS AND METHODS
Bacteria and Phage Strain and Propagation
Bacterial host strains used were S. aureus ATCC 19685 and E.
coli ATCC 11303 strain B. Both strains were sourced from LGC
standards, United Kingdom (UK). S. aureus bacteriophage K
ATCC 1985-B1 (family Myoviridae) and E. coli bacteriophage
ATCC R© 11303-B3 (family Podoviridae, T3) were also sourced
from LGC standards, UK.
S. aureus bacterial host strain and phage were propagated
in liquid culture using Brain Heart Infusion (BHI, Oxoid, UK).
Luria Broth (LB, Oxoid, UK) was used to grow E. coli. For
S. aureus phage propagation, a single colony from a streaked
overnight culture on a BHI agar plate was used to inoculate
fresh BHI broth and left shaking overnight at 37◦C. The culture
was diluted to O.D. 0.05 and regrown to log phase between 0.2
and 0.3 O.D. (λ = 600 nm) for all phage work. To evaluate
actual MOI a 10 µl sample was withdrawn and serially diluted
to measure the CFU/ml of the sample at the point prior of
addition of a known quantity of phage. Previously, growth curves
were measured where both the O.D. and corresponding CFU/ml
measurements were obtained under identical growth conditions;
the measurements were reliably repeatable (data not shown).
The correspondence between growth curve CFU/ml and O.D.
values gave us confidence that using O.D. values between 0.2
and 0.3 for both S. aureus and E. coli corresponded to ∼108
CFU/ml prior to phage addition. At this point bacteriophages
of known titer were added to the culture at a multiplicity of
infection (MOI) of ∼0.01. Once the culture had cleared (∼6 h
later) the lysate was centrifuged at 2,000 g for 15min at 4◦C
and the supernatant filtered using a 0.22µm pore size in-
line syringe filter (Millipore, USA). Hundred kilo Daltons of
MWCO tangential flow ultrafiltration cassettes (MerckMillipore,
UK) were used for exchange of lysate media with SM buffer
(50mM of Tris-HCl, pH of 7.5, 100mM NaCl, 10mM MgSO4,
all chemicals purchased from Fisher Scientific, UK) and if needed
to concentrate the phage titer. All phage samples were stored in
SM buffer at 4◦C until further use.
To titer the phage samples, phage solutions were serially
diluted and spotted (six replicates) on a double layer agar plate
(Adams, 1959). The plate was dried near a flame and then
incubated overnight at 37◦C. On the following day plaques were
counted to determine the phage titer and expressed as plaque
forming units PFU ml −1.
Reagent Chemicals
Phospholipid DSPC (1,2-distearoyl-sn-glycero-3-
phosphocholine) was purchased in dry powder form from
BACHEM (Bubendorf, Switzerland) and was used without any
further purification. Cholesterol ≥99%, Chloroform anhydrous
≥99%, Isopropanol anhydrous 99.5%, and Triton X-100 were
purchased from Sigma-Aldrich, UK. Ethanol 99.5% (extra dry)
was purchased from Fisher Scientific, UK.
Co-flow Microfluidic Device Fabrication
The co-flow microfluidic (MF) device used for liposome
formation was fabricated in-house following the procedure
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reported earlier (Vladisavljevic et al., 2014). The main body
of the MF device consisted of two coaxial borosilicate glass
capillaries glued onto a microscope glass slide. To assemble the
device, a round tapered-end borosilicate glass capillary (Intracel,
Royston, UK) with a 1mm outer diameter, 0.58mm inner
diameter, and 100–200µm orifice diameter was inserted halfway
into an outer square glass capillary (1mm inner dimension,
AIT Glass, Rockaway, US) and aligned (see Figure 1). A P-97
Flaming/Brown micropipette puller (Sutter Instrument Co.,
USA) was used to produce a sharp capillary tip of about 20µm in
diameter. The orifice size of inner capillary was then increased by
sanding the tip against sand paper until the orifice with a required
size and smooth rim was obtained. The orifice size was controlled
using a Narishige’s MF-830 microforge microscope (Intracel Ltd.,
Stephenson, UK). Two syringe needles (BD Precisionglide R©,
Sigma–Aldrich, O.D. 0.9mm) and PTFE tubing (I.D. 0.8mm)
were used to deliver the organic phase and the aqueous phage
solution.
Generation of Liposomes
Liposomes were produced using the MF device described
above (Figure 1) and the method of direct co-flow alcohol
injection (Vladisavljevic et al., 2014). Lipid solutions (with
different DSPC:cholesterol ratios) were prepared by dissolution
of lipids in chloroform in a round bottom flask. The lipids
were dried using a rotary evaporator for 2 h to obtain a thin
film, and subsequently further dried overnight under vacuum.
Isopropanol (IPA) was used to solubilize the film of lipids to a
final concentration of 10mg ml−1. The organic lipid solution
and the aqueous buffer solution were delivered, respectively,
through the inner tapered round capillary and the outer square
capillary by means of Vici Model M6 microfluidic pumps (Valco
Instruments Co. Inc.,). The flow rates of the organic phase,
Qo and the aqueous phase, Qa were adjusted to control the
degree of hydrodynamic focusing and the width of the central
stream, thus controlling the IPA/buffer micromixing process.
The flow rate ratio (FRR= Qa:Qo) between the outer aqueous
phase and the inner organic phase of 2:1 was used. The MF
device was immersed in a water bath and allowed to reach
thermal steady state under experimental conditions to ensure
the experiments were performed under constant temperature.
The IPA solution was filtered through 0.1µm PVDF syringe
filters (Fisher Scientific, UK) prior to pumping through the MF
device. Liposomes were collected in sterile glass vials (Fisher
Scientific, UK).
Nanoencapsulation of Bacteriophage in
Vesicles
Bacteriophages were encapsulated in liposomes as per the
procedure outlined above. Purified concentrated bacteriophages
in SM buffer were prepared at titers >1011 PFU/ml. This
concentrated phage stock was diluted to the appropriate working
concentration by mixing with SM buffer prior to use in the
MF device if lower concentrations of phage were used for
encapsulation (working concentrations were varied as needed in
the range 109-1010 PFU/ml). The aqueous phage solution was
delivered through the outer capillary, while the organic lipid
solution was injected through the inner capillary.
Determination of Encapsulated
Bacteriophage K Titers
Separation of Free S. aureus Phage K From
Liposome Suspensions
The S. aureus phage K product stream collected from the MF
device containing a mixture of free and encapsulated phages
was dialyzed (Visking Dialysis Membranes, Molecular Weight
Cut-off 3,500 Da) overnight against SM buffer (pH 7.5) to
remove residual isopropanol. Free K phages were separated from
liposomes using a 0.22µm MidGee hoop ultrafiltration hollow
fiber tangential flow cartridge with a 1ml hold-up volume (GE
Healthcare, UK). Themembrane flux was 2 l/m2.h and run for 8 h
until no further change in retentate phage titer was recorded. The
liposomes were retained in the retentate and free phage removed
in the permeate.
Removal of Liposome Bound S. aureus Phage K
To evaluate the binding of free K phages to liposomes, empty
liposomes (formulation described previously) at a concentration
of 1010 liposomes/ml were gently mixed with phage K solution
(final concentration in liposome solution ∼1010 PFU/ml). The
total volume was 1ml. The empty liposomes were left in contact
with K phages for 15min at either 4, 25, or 37◦C to allow the
phages to adsorb to the liposomes. Liposomes were separated
from unbound free phages by centrifugation at 13,000 g for 3min
and phage titer in the supernatant was measured using double
overlay plaque assay technique.
To evaluate the inactivation of liposome bound phages, empty
liposomes were left in contact with K phages for 15min at 37◦C to
allow the phages to adsorb to the liposomes (as described above).
The solution was then dialyzed against SM buffer (pH 2.75)
for 60min. The solution was subsequently neutralized with
NaOH (0.1M) followed by measurement of the phage titer by
double overlay plaque assay technique. All phages were rendered
unviable.
Inactivation of phage K adsorbed to the liposome bilayer
membrane was undertaken to evaluate the encapsulated phage
K titer. Liposomes containing K phages were exposed to pH
2.75 to inactivate the liposome adsorbed phages. Phage K were
prepared in a pH 5.5 SM buffer and were encapsulated using
the microfluidic device as per the procedure described above.
The lower pH of the buffer was used to reduce the proton
concentration gradient and therefore the proton flux across
the membrane to minimize pH change within the liposome
compartment (Deamer, 1987). Encapsulation at pH 7.5 was
found to result in complete inactivation of phage K in the
liposomes exposed to pH 2.75 hence lowering of the internal
pH to pH 5.5 was undertaken which resulted in viable phage
recovery. Phage K titer was stable over a period of 24 h in pH
5.5 buffered solution. Phage K was completely inactivated (10 log
reduction) at pH 4 (data not shown).
Free phage K (titer ∼1010 PFU/ml) was dialyzed against SM
buffer (pH 2.75) for 60min. The solution was subsequently
neutralized with NaOH (0.1M) followed by measurement of the
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FIGURE 1 | Schematic showing the microcapillary micromixing device for the production of liposomes. (A) 3D model of the co-axial glass capillary device. Solutions
were pumped using two microfluidic pumps using a total flow rate of ∼1ml h−1 and a flow rate ratio (FRR) of aqueous to organic phase (Qa:Qo) of 2:1. (B) The round
capillary was inserted into a square capillary that delivered the aqueous phase containing phages. The internal round capillary delivered the lipid dissolved in IPA
solution. (C) Once the organic phase mixes with the aqueous phase, the phospholipids experience a highly polar environment that leads to self-assembly of lipids into
bilayer discs. The latter grow in the radial direction by collision with other discs or through addition of phospholipid molecules from solution. When the disc bending
energy is overcome by the energy gain when the edge around the bilayer disc is removed, the planar bilayer closes upon itself resulting in a spherical structure
entrapping the surrounding solution and any phages in the vicinity of the bilayer.
phage titer by double overlay plaque assay technique. All free
phages were rendered unviable.
The liposome samples containing encapsulated phages was
dialyzed against SM buffer (pH 2.75) for 60min, subsequently
neutralized with NaOH (0.1M) followed by measurement of the
phage titer by double overlay plaque assay technique to ensure
that all remaining free phages were rendered unviable. The pH
in the dialysis bag was measured and attained at pH 2.75 within
30min. Encapsulated phages were then released by disrupting the
liposomes with Triton X-100 according to a previously described
protocol (Patra et al., 1998). The final concentration of both
Triton X-100 and (NH4)2SO4 in the liposomal dispersion was
5mM. The sample was left in a water bath at 40◦C for 1 h and
the phage titer after disruption of the liposomes was assessed by
plaque assay.We found that at 40◦C there was no change in phage
titer for both phage K and T3 phages (data not shown).
Determination of Encapsulated
Bacteriophage T3 Titers
Separation of Free E. coli T3 Phages From Liposome
Suspensions
E. coli T3 bacteriophages were encapsulated in liposomes as
per the procedure outlined above. The titer of phages in the
liposome collection vial was evaluated to give an indication of
the inactivation of T3 phages due to exposure to IPA. Free T3
phages were separated from liposomes by centrifugation at 9,000
× g for 5min. The liposome pellet was resuspended in SM buffer
at pH 7.5, this procedure was repeated three times to remove free
T3 phages and titer of phages measured. Encapsulated phages
were then released by disrupting the liposomes with Triton X-100
according to a previously described protocol.
To evaluate the effect of phage T3 titer on encapsulation yield,
three different initial titers of phage T3 (109, 1010, 1011 PFU/ml)
were used for encapsulation. The process of encapsulation was
identical to the method described above. Following separation
of free phages from liposomes by centrifugation (details
above), encapsulated T3 phages were released by disrupting the
liposomes with Triton X-100 (described above) and encapsulated
phage titer was assessed by plaque assay.
Characterization
Liposome Size and Size Distribution
A NanoSight LM10 (Malvern Instruments Ltd., UK) using
nanoparticle tracking analysis (NTA) was used to determine
the average size and size distribution of both liposomes and
bacteriophages. NTA measurements were performed in a sample
chamber equipped with a 640 nm laser to track the NPs.
Typically, a 10 µl aliquot was taken from each sample and
diluted 102-103 fold in order to achieve a particle concentration
of 107-1010 particles ml−1. The sample was injected into the
sample chamber using a sterile syringe and sample flow was
maintained through the chamber until all air bubbles were
removed. The temperature was registered with a thermometer
(RTD Pt100, OMEGA, UK) and temperature correction was
carried out. The software used for capturing and analyzing the
data was NTA 3.0 (Malvern Instruments Ltd., UK). Data for each
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sample was captured over a period of 60 s and each measurement
was repeated five times. The focus was set to achieve a uniform
perfect spherical particle view. Before capturing the video, the
camera had to set-up to ensure all the particles in the sample were
clearly visible with no more than the 20% saturation. The single
gain mode was used throughout the whole measurement process.
Statistical analysis was carried out using the NTA software.
Cryo-Transmission Electron Microscopy
(Cryo-TEM)
An 8 µl aliquot of sample was pipetted onto a carbon coated
copper grid (HC300Cu, Holey Carbon film on Copper 300 mesh,
EM Resolutions, UK). Excess liquid was blotted away with filter
paper (Whatman number 1) and the grid was plunge-frozen in a
liquid mixture of ethane/propane cooled by liquid nitrogen. The
sample was then kept at liquid nitrogen temperatures throughout
the analysis. TEM images were taken on a JEOL 2200FS TEM at
200 keV using a Gatan K2 Summit and Gatan 914 cryo-holder.
RESULTS
Increasing the concentration of added cholesterol in the liposome
formulation resulted in an increase in the liposome mean
size and broadening of the size distribution (Figure 2A). NTA
measurements indicated that the mean size of the liposomes
increased with the amount of added cholesterol from 134 ±
13 nm for pure DSPC, to 206 ± 28 nm for a DSPC:cholesterol
molar ratio of 5:1 and finally 301± 32 nm for a DSPC:cholesterol
molar ratio of 1:1.
The morphology and size of phage T3 (Podoviridae family;
phage dimensions ∼65 nm) and phage K (Myoviridae family,
capsid head ∼80 nm and phage tail length ∼200 nm) were
visualized using cryo-TEM (Figure 3). Concentrated purified
phages in SM buffer were initially prepared at high phage
titers of ∼1010 PFU ml−1 on the premise that there would be
an increasing likelihood of phage encapsulation in liposomes
resulting in higher phage encapsulation yield, but high phage
titers promoted phage aggregation. Phage aggregation into
larger clusters was observed for T3 at relatively low phage
concentrations, as low as 107 PFU ml−1. However, phage K
showed noticeable aggregation only when phage titers were
∼1010 PFU ml−1 (Figure 3). T3 phages were more susceptible
to aggregation due to the compact shape of their tail-free heads.
Phage K began to aggregate only at high concentrations due to
steric hindrance imposed by the long tails of these phages.
The clusters of both phages were found to be stable at
high phage concentrations irrespective of ionic strength of
the solution, since the presence of various salts at different
concentrations did not affect the size of the clusters (data not
shown). Dilution of phages resulted in a reduction in the average
cluster size suggesting the aggregation process was reversible
(Figure 3). The average size of phage clusters is dictated by the
dynamic equilibrium between the rate of aggregation due to
attractive Van der Waals forces acting between the phages and
the rate of disaggregation due to their thermal motion. The rate
of phage aggregation increases with an increasing rate of phage
collisions in the solution, which is proportional to the phage
concentration. Therefore, phages in more concentrated solutions
are more prone to aggregation. The size of the aggregates formed
at high phage concentrations was similar to the average size
of the liposomes formed using the microfluidic device thereby
limiting the likelihood of phage encapsulation in the formed
liposomes. We found increasing the T3 phage titer did not
yield correspondingly higher titers of encapsulated phages in
liposomes (discussed later).
The morphology and structure of the liposome-encapsulated
phages were visualized using cryo-TEM (Figure 4). The
liposomes were typically found to be unilamellar with a
high proportion of empty liposomes and large numbers of
unencapsulated phages (Figure S1). Unilamellar vesicles are
usually prepared using significant energy inputs supplied by
sonication or extrusion through a membrane at high pressure.
Here, unilamellar vesicles were formed using a low energy
method. The thickness of the bilayer membrane on cryo-TEM
images is 4–5 nm, which corresponds to the thickness of the
DSPC bilayer ∼4.2 nm estimated from small angle neutron and
X-ray scattering data (Kucˇerka et al., 2011).
Due to the relatively large head and long tail, phage K
were found encapsulated only in large liposomes (∼500 nm
or bigger) which were formed using DSPC:cholesterol molar
ratio of 5:1. Encapsulated liposomes contained typically one and
sometimes two phages per liposome (Figure 4A). Verification
of the encapsulation of phage K within the liposome was
achieved through tilting of the sample during observation
using tomography and reconstruction of the three dimensional
structure of the liposome encapsulated phage (tomography
reconstruction and extended looped video provided as
Supplementary Materials). The tomography image shows
layer-by-layer reconstruction of phage K located within the
liposome. Multiple phage K tails were observed to frequently
interact with the lipid bilayer and bind to the outside wall of
the fully formed liposomes as well as lipid bilayer fragments
(Figures 4B,C). Schematic representations of encapsulated and
externally bound phages are also shown (Figures 4A.1–C.1).
Liposome suspensions containing encapsulated phage K
prepared using the formulation with a DSPC:cholesterol molar
ratio of 5:1 were tittered for free phages before [sample mean
2.1 × 107 PFU/ml, 95% Confidence Interval (CI) 1.1 × 107-
3.2 × 107 PFU/ml] and after disruption of the liposomes
(sample mean 4 × 107 PFU/ml, 95% CI 2.1 × 107-5.9 × 107
PFU/ml) following treatment with Triton X-100 to disrupt the
liposomes (Figure 5A). Disruption of the liposomes did not
result in a statistically significant change in measured phage titers
(p = 0.068). The phages remained viable following treatment
with Triton X-100 (this was also the case for T3 phages, data not
shown). Liposome suspensions containing free and encapsulated
K phages were then exposed to pH 2.75 to inactivate free and
liposome bound phages. Acid exposure of liposomes (containing
K phages at pH 5.5) resulted in a significant reduction in phage
titer (sample mean 2.6× 104 PFU/ml, 95% CI 1.3× 104-4× 104
PFU/ml). Acid exposed liposomes were subsequently disrupted
with Triton X-100 to release any viable K phages remaining inside
the liposomes. Disruption of liposomes resulted in a significant
Frontiers in Microbiology | www.frontiersin.org 6 September 2018 | Volume 9 | Article 2172
Cinquerrui et al. Microfluidic Nanoencapsulation of Bacteriophages in Liposomes
FIGURE 2 | NanoSight measurements of the size distributions of liposomes formed using different DSPC:cholesterol molar ratios: (A) DSPC only (dotted line), 5:1
DSPC:cholesterol molar ratio (dashed line), and 1:1 DSPC:cholesterol molar ratio (solid line). Liposomes were prepared at room temperature (∼20◦C) using aqueous
to organic phase volumetric flow rate ratio FRR of 2:1 and the total volumetric flow rate of ∼1ml h−1. (B) Inset showing average mean sizes, error bars indicate one
standard deviation. *Indicates significance (p < 0.05) using 2-sample t-test.
increase in phage titer (sample mean 2.4 × 105 PFU/ml, 95%
CI 1.8 × 105-3 × 105 PFU/ml). The 95% CI for the increase in
phage titer upon liposome disruption was 1.5 × 105-2.7 × 105
PFU/ml which is indicative of the yield of encapsulated phage
K in the liposomes. It was not possible to quantify the loss (if
any) in titer of encapsulated phage K due to acid exposure. When
the same experiment was carried out with the pH inside the
liposomes kept at pH 7.5 and liposomes subsequently exposed to
pH 2.75, no viable phages were recovered. Encapsulating phage
K using a pH 5.5 buffer allowed us to have a lower pH inside
the liposome which reduced the pH gradient across the liposome
membrane bilayer to less than 1pH 3 and hence reduced the
driving force for proton flux (Deamer, 1987). A reverse of this
approach has been used previously to load liposomes with drugs
in response to transmembrane pH gradients (Mayer et al., 1990).
The reduction in phage titer following acid exposure to pH
2.75 may be attributed to inactivation of both free phages and
phages externally bound to the liposomes which was confirmed
separately (Figure 5C).
Empty liposomes prepared using the formulation with a
DSPC:cholesterol molar ratio of 5:1 were gently mixed with free
phage K for 15min at 4, 25, and 37◦C. A considerable amount
of phages adsorbed to the outer surface of empty liposomes
resulting in a significant decrease in phage titer of the supernatant
for all investigated temperatures (Figure 5B). Exposure to pH
2.75 of the K phages bound to empty liposomes resulted in no
recovery of viable phages (Figure 5C), suggesting that K phages
bound to the outside of the liposomes were not protected from
acid exposure and were inactivated. In addition, free phages
present in solution without the presence of any liposomes
were also completely inactivated after exposure to pH 2.75
(Figure 5C). On the other hand, phages truly encapsulated in
liposomes were able to withstand acid exposure. This procedure
provided a means of discriminating between free phages, phages
externally bound to liposomes and phages actually encapsulated
within the liposomes.
The encapsulation process resulted in a significant reduction
in phage T3 titer upon exposure to IPA during the liposome
formation process (Figure 6A). The phage titer fell from
2.4× 109 PFU/ml (95% CI 1.1 × 109-3.7 × 109 PFU/ml) to
8.7 × 107 PFU/ml (95% CI 4.5 × 107-1.3 × 108 PFU/ml).
Removal of free phages by centrifugation and resuspension in
SM buffer resulted in phage T3 titer reduction from 8.7 × 107
to 2.1 × 107 PFU/ml (95% CI 1.3 × 107-2.8 × 107 PFU/ml).
Disruption of the liposomes with Triton X-100 resulted in a
significant increase in phage titer to 8.1 × 107 PFU/ml (95%
CI 3.1 × 107-1.3 × 108 PFU/ml) (Figure 6A). The difference
in means was 6.1 × 107 PFU/ml (95% CI 1 × 107-1.1 × 108
PFU/ml) which is an estimation of the phage T3 encapsulation
yield.
Increasing free phage T3 titers used in the MF device
for encapsulation from ∼109 to ∼1010 PFU/ml resulted in a
significant increase in encapsulated phage yield from 8.1 × 107
PFU/ml (95% CI 3.1 × 107-1.3 × 108 PFU/ml) to 3.5 × 109
PFU/ml (95% CI 1.9 × 109-5.2 × 109 PFU/ml) (Figure 6B).
Increasing the free phage T3 titers further to ∼1011 PFU/ml
resulted in a lower encapsulated phage yield with sample mean
falling to 1.5× 109 PFU/ml (95%CI 7.5× 107-2.8× 109 PFU/ml)
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FIGURE 3 | NanoSight NTA measurements of size distributions of purified T3 phage (left) and phage K (right), respectively, at 107, 108, 109 and 108, 109, 1010
PFU/ml. Insets show CryoTEM images of observed phage aggregates and the schematized depiction of phage cluster sizes as a function of phage titer. Some heads
on the lower CryoTEM images are transparent (empty), probably due to denaturation of DNA during encapsulation or loss of DNA during CryoTEM imaging.
(Figure 6B). The encapsulated phage yield was lower for the
sample prepared using higher phage titer of ∼1011 PFU/ml
compared with∼1010 PFU/ml.
DISCUSSION
Micromixing of the lipid-containing organic phase with the
aqueous buffer resulted in self-assembly of lipid bilayers in
the collection channel of the MF device. This process is
driven by hydrophobic effects in order to minimize entropically
unfavorable interactions between the hydrophobic acyl chains
and the surrounding aqueous buffer phase (Carugo et al.,
2016). The lipid-in-alcohol stream was sheathed by a coaxial
aqueous stream resulting in hydrodynamic flow focusing of
the core fluid (Vladisavljevic et al., 2014). Microfluidic flow
focusing permitted mixing of the two phases under low Reynolds
number flow conditions (Re ∼1) and diffusion dominated mass
transfer (Peclet number <1) resulting in controlled production
of nanoscale liposomes (Jahn et al., 2004). A 3D geometry
of the MF device allowed radially symmetric interdiffusion of
IPA-solvated lipids, alcohol, and water across the alcohol-water
interface which offers advantages including low polydispersity
and higher production rates (Hood et al., 2014). The cross-
sectional area of the core solution may be tuned by adjusting the
orifice size of the injection capillary and the FRR of the outer
(aqueous) and inner (organic) phases (Jahn et al., 2010). At low
Reynolds and Peclet numbers used in this work laminar flow
conditions prevailed in the downstream capillary and liposome
formation was dominated by diffusion rather than advection.
The microfluidic micromixing process allowed predictable and
repeatable mixing across fluid interfaces and the continuous
synthesis of liposomes of narrow size distributions and controlled
size which could be modulated by controlling FRR, the total flow
rate and composition of the lipids. The addition of cholesterol
makes the assembled bilayers more rigid and therefore, more
energy and time is required for their closure (Sawant and
Torchilin, 2012a). Liposome formation in microchannels at low
temperatures has been shown to result in larger liposomes
compared with those produced under identical conditions
albeit at higher temperatures (Wi et al., 2012). Increasing the
proportion of organic phase to aqueous phase results in a
shallower lipid concentration gradient and has previously been
shown to result in larger liposomes for the same formulation
(Jahn et al., 2010; Leung et al., 2018). We employed a FRR of 2:1
and a low total flow rate of∼1ml h−1 which resulted in liposome
sizes of the same order as those reported elsewhere under similar
hydrodynamic conditions (Wi et al., 2012; Carugo et al., 2016;
Leung et al., 2018).
Evidence of disc-like non-equilibrium lipid aggregates in a
region close to the immediate mixing zone of the two phases
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FIGURE 4 | Cryo-TEM images showing (A) encapsulation of phage K, and (B,C) interaction between phage K tails and the outer leaflet of the bilayer membrane of
formed liposomes (DSPC:cholesterol molar ratio was 5:1), some tails look contracted. (A1–C1) Schematized depiction showing encapsulation of phage K within the
liposome (favored outcome) and interaction of phage K with the outer surface of unilamellar liposome membrane and lipid bilayer (unfavorable outcome). (D) Chemical
structure of DSPC and (E) chemical structure of teichoic acid (phosphate groups highlighted in red).
in a microfluidic channel was recently shown using cryo-
ultramicrotomy and cryo-SEM (Jahn et al., 2013). Time is needed
for lipid molecules to diffuse and aggregate; the concentration
gradient of alcohol has a significant effect on the liposome
formation process with gentle gradients (low FRR) favoring large
liposome formation (Jahn et al., 2013). The closure of lipid
bilayers may incidentally trap any bacteriophages in the vicinity
of the enclosing lipid membrane and the number of phages
encapsulated per vesicle is dictated by Poisson statistics. Parabolic
velocity profile in pressure driven laminar flows results in the
velocity decreasing toward the capillary wall which affects axial
and radial concentration profiles and the distribution of liposome
sizes formed. A number of factors may be responsible for the
observed polydispersity of the liposomes formed (Figure 2). The
rate of mass transfer of the lipids is affected by the velocity
distribution along and across the channel resulting in variations
in mixing times across and along the microcapillary affecting the
size distribution of the liposomes formed. Our intention in this
work was not to study these effects which have been considered
in detail elsewhere (Fernandez-Puente et al., 1994; Zook and
Vreeland, 2010; Carugo et al., 2016).
A number of previous studies have noted albeit briefly that
encapsulation of phages in liposomes prepared using either the
thin film hydrationmethod ormicrofluidic micromixing resulted
in empty liposomes and noted that phages were attached to
the outside of the liposomes (Colom et al., 2015; Nieth et al.,
2015a; Leung et al., 2018). However, to the best of our knowledge
none of these studies went further to quantify and decouple
the proportion of phages truly encapsulated in the liposomes
and those that were externally bound to the lipid membranes.
Previous studies have used high titers of phages (1010-1011
PFU ml−1) in order to achieve high reported yields of what are
thought to be “encapsulated phages” (Colom et al., 2015; Chadha
et al., 2017; Leung et al., 2018). However, consideration needs
to be given to phage aggregation, which is more significant at
higher phage concentrations. The resulting phage clusters may be
too big to be physically encapsulated within formed liposomes.
We found increasing the phage T3 titer from 109 to 1010 PFU
ml−1 initially increased the encapsulated phage yield. Increasing
the phage titer further to 1011 PFU ml−1 resulted in lowering
of the phage T3 encapsulation yield (Figure 6B). This may be
attributed to the formation of large phage T3 aggregates at high
phage titers that are either too big to encapsulate in the liposomes
or diffuse too slowly and are not in the vicinity of closing bilayers
and therefore are not trapped in the liposomes (Figure 3). Other
studies have reported phage aggregation and formation of cluster
rosettes (Serwer et al., 2007; Bourdin et al., 2014). Methods for
dispersion of phage aggregates may help in this regard (Szermer-
Olearnik et al., 2017).
Our results suggest that the actual encapsulation yield of
S. aureus K phages inside the liposomes may be considerably
overestimated unless externally bound phages are accounted
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FIGURE 5 | (A) S. aureus phage K encapsulation in DSPC:cholesterol liposomes. Phages were encapsulated at FRR of 2:1 at room temperature. Phage titer of
liposome encapsulated phages prior to and after acid exposure at pH 2.75 (with and without Triton X-100 disruption). *Indicates significance (p < 0.05) using
2-sample t-test. (B) The titer of free phages in the supernatant before and after incubation with empty liposomes at 4, 25, and 37◦C for 15min. After incubation,
liposomes were separated by centrifugation at 13,000 × g for 3min and the phage titer in the supernatant was measured. The difference in the titer occurred due to
phage adsorption onto the outer leaflet of bilayer membranes. The maximum phage adsorption was observed at 4◦C, which caused the highest phage titer reduction
in the supernatant at 4◦C. The adsorption was still highly significant at 37◦C. *Indicates significance (p < 0.05) using 2-sample t-test of each sample compared with
controls. (C) pH stability for free (non-encapsulated) phage K exposed to pH 2.75 and free phage K incubated with pre-made empty liposomes for 15min at 37◦C
and subsequently dialyzed at pH 2.75 for 60min. Error bars represent one standard deviation.
for. S. aureus phage K may bind to the lipid bilayers due to
electrostatic interactions between negatively charged phosphate
groups on the phospholipid head (shown in red in Figure 4D)
and positively charged residues on the tail fibers of the phages.
This interaction resembles a reversible interaction between
phages and their hosts via wall teichoic acids, e.g., glycopolymers
present in Gram-positive bacterial cell membranes (Figure 4E)
(Xia et al., 2011). The reported encapsulation efficiencies have
ranged between 40 and 80% which for large tailed phages may
be attributed to phages externally bound to the lipid bilayers
(Colom et al., 2015; Chadha et al., 2017; Leung et al., 2018). The
adsorption process is reversible leading to a dynamic equilibrium
between bound and unbound phages (Baptista et al., 2008;
Xia et al., 2011). In a previous study, a 60min exposure of
liposome encapsulated Salmonella phages (prepared using thin
film hydration technique) to simulated gastric fluid (pH 2.8)
resulted in a significant reduction in phage titer (by 4–5 orders of
magnitude) which mirrors the results reported here (Figure 5A)
(Colom et al., 2015). In an effort to minimize acid induced
phage inactivation within the internal liposome compartment
we reduced the transmembrane pH gradient between the
liposome core and the external solution to minimize proton
permeability across the DSPC-cholesterol lipid membrane (Biloti
et al., 2003). Phage encapsulated liposomes exposed to pH 2.75
showed a significant fall in phage titer to 104 PFU ml−1 with
a statistically significant increase of ∼1 log in phage K titer
upon liposome disruption with Triton X-100 indicating that
some or perhaps all encapsulated phages survived the acid
treatment. The encapsulated phage K titer was however quite
low ∼105 PFU ml−1. Following liposome formation external
phages may subsequently bind to the outer liposome membrane.
Cryo-TEM images suggested that only one or two phages were
encapsulated in each liposome. A 1 log increase in phage titer
upon liposome disruption suggests that removal of free phages
and inactivation of bound phages followed by disruption of
the liposomes provides a means for evaluating the titer of
encapsulated phages.
We only observed phage K bound to the outside of
the formed liposomes and not when they were encapsulated
inside the aqueous core. This may be due to the rate of
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FIGURE 6 | E. coli T3 phage encapsulation in DSPC:cholesterol liposomes.
T3 phages were encapsulated at FRR of 2:1 at room temperature. Free
phages were separated by centrifugation for 10min at 13,000 × g and
re-suspended in SM buffer, the process was repeated three times to remove
unencapsulated phages. Liposomes were disrupted with Triton X-100 and
phage titer assessed by plaque assay. (A) Phage T3 titers following
encapsulation, after removal of unencapsulated free phages (following three
wash steps) and after liposome disruption with Triton X-100. (B) Phage
encapsulation yield using different initial phage titers and after encapsulation,
free phage removal by centrifugation (as above) and then liposome disruption
with Triton X-100. *Indicates significance (p < 0.05) using 2-sample t-test.
formation of liposomes being much faster than the rate of
interaction of phage K with the formed bilayer structures.
The considerably faster interdiffusion of small molecules e.g.,
IPA and water may result in liposome formation in a zone
close to the organic-aqueous interface. We hypothesize that
due to their considerably larger size and hence much slower
diffusion, phages may not be able to get near the vicinity
of a large majority of rapidly forming bilayer discs in time
to be encapsulated when the bilayers close resulting in low
phage encapsulation yield. Aggregation of phages even at low
phage titers compounds this effect making it problematic. Future
efforts need to consider strategies to overcome these inherent
difficulties if microfluidic approaches are to be successfully
employed to encapsulate large entities such as bacteriophages in
nanostructured materials.
CONCLUSIONS
We have demonstrated the controlled microfluidic production
of liposomes with a mean size in the range of 100–300 nm.
The size of the liposomes may be controlled by incorporating
different amounts of cholesterol in a formulation containing the
phospholipid DSPC and regulating the hydrodynamic conditions
within the microfluidic micromixing device, in particular the
FRR of aqueous to organic phases. We show that the yield
of T3 encapsulated phages may be adversely affected by
aggregation which limited the maximum attainable yield of
encapsulated T3 phages ∼109 PFU/ml. S. aureus phage K was
found to adsorb to the external lipid membranes resulting in
large numbers of phages bound to the outside of the formed
liposome instead of being trapped inside them. We developed a
method that permitted inactivation of liposome-bound K phages
whilst retaining the activity of phages encapsulated within the
liposomes. This allowed estimation of the encapsulated phage
K yield which was found to be low ∼105 PFU/ml. Inactivation
of encapsulated phage K due to acid exposure cannot be ruled
out and needs further work. Previous studies on tailed phage
encapsulation in liposomes may therefore have overestimated
the yield of encapsulated phages which may affect the efficacy
of phage dose delivered at the site of infection. In the case of
treatment of gastrointestinal infections externally bound phages
may be inactivated due to the stomach acidity.
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Figure S1 | Cryo-TEM images showing non-encapsulated S. aureus phage K and
E. Coli T3 phages and empty unilamellar liposomes. (a) Phage K (yellow arrow)
and a unilamellar liposome (red arrow) (b) T3 phages (yellow arrows), some of
them with empty heads and unilamellar liposomes (red arrows). Images presented
for formulation (DSPC:cholesterol molar ratio was 5:1), FRR 2:1.
Video S1 | Visualization of S. aureus phage K encapsulation in liposomes by
Cryo-TEM tomography - extended video.
Video S2 | Visualization of S. aureus phage K encapsulation in liposomes by
Cryo-TEM and tomography reconstruction.
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